Specification of haematopoietic stem cell fate via modulation of mitochondrial activity by Vannini, Nicola et al.
ARTICLE
Received 18 Nov 2015 | Accepted 5 Sep 2016 | Published 12 Oct 2016
Speciﬁcation of haematopoietic stem cell fate
via modulation of mitochondrial activity
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Haematopoietic stem cells (HSCs) differ from their committed progeny by relying primarily
on anaerobic glycolysis rather than mitochondrial oxidative phosphorylation for energy
production. However, whether this change in the metabolic program is the cause or the
consequence of the unique function of HSCs remains unknown. Here we show that enforced
modulation of energy metabolism impacts HSC self-renewal. Lowering the mitochondrial
activity of HSCs by chemically uncoupling the electron transport chain drives self-renewal
under culture conditions that normally induce rapid differentiation. We demonstrate that this
metabolic speciﬁcation of HSC fate occurs through the reversible decrease of mitochondrial
mass by autophagy. Our data thus reveal a causal relationship between mitochondrial
metabolism and fate choice of HSCs and also provide a valuable tool to expand HSCs outside
of their native bone marrow niches.
DOI: 10.1038/ncomms13125 OPEN
1 Laboratory of Stem Cell Bioengineering, Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Fe´de´rale de
Lausanne (EPFL), CH-1015 Lausanne, Switzerland. 2 Laboratory of Regenerative Hematopoiesis (GR-NAVEIRAS), Institute of Bioengineering, School of Life
Sciences, Ecole Polytechnique Fe´de´rale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland. 3 Departments of Medicine and Oncology, Centre Hospitalier
Universitaire Vaudois (CHUV), CH-1011 Lausanne, Switzerland. 4 Laboratory of Integrative and Systems Physiology, Institute of Bioengineering, School of Life
Sciences, Ecole Polytechnique Fe´de´rale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland. 5 Institute of Chemical Sciences and Engineering, School of Basic
Science, Ecole Polytechnique Fe´de´rale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland. * These authors contributed equally to this work. Correspondence
and requests for materials should be addressed to M.P.L. (email: matthias.lutolf@epﬂ.ch).
NATURE COMMUNICATIONS | 7:13125 | DOI: 10.1038/ncomms13125 |www.nature.com/naturecommunications 1
T
he maintenance of the blood system is ensured by a pool of
HSCs residing in hypoxic niches in the bone marrow
(BM)1. These unique cells are capable of lifelong
self-renewal and commitment to multipotent progenitors
(MPP). For many decades, HSCs have been successfully used
for treating haematological and immune diseases. However, their
limited number, especially when isolated from umbilical cord,
prevents a more reliable and broader application of HSC-based
therapies2–4. Despite recent notable success stories5,6, many
attempts to propagate HSCs in vitro have failed, primarily
because self-renewal and in vivo regenerative capacity is rapidly
lost in culture.
Recent studies have shown that the change in cell identity and
function during early HSC commitment involves a profound
alteration in the metabolic program of the cells. Long-term HSCs
(LT-HSCs) are mostly quiescent and tend to produce energy
preferentially by anaerobic glycolysis1,7,8, which has been linked
to their residence in low oxygen niches9,10. In contrast, the
stem and progenitor cell types that produce blood and have a
reduced self-renewal ability (that is, short-term HSCs and rapidly
proliferating MPPs) generate ATP primarily in the mitochondria
by oxidative phosphorylation (OXPHOS)7,11. The distinct
metabolic program of LT-HSCs appears to play a critical role
in maintaining their long-term in vivo function, presumably
because the reduced mitochondrial respiration protects the cells
from cellular damage inﬂicted by reactive oxygen species (ROS)
in active mitochondria12–16.
The metabolic switch that occurs during the earliest step of
adult haematopoiesis suggests a direct role of mitochondria
in regulating HSC fate. This hypothesis is supported by
work demonstrating that a metabolic transducer, the tumour
suppressor and glucose sensor Lkb1 is crucial for HSC
maintenance16–19. Moreover, autophagy, through which cells
can modulate mitochondrial numbers, has been shown to
improve HSC maintenance20. However, whether the metabolic
state of HSCs is more than an adaptation to an extreme
microenvironment in the BM, and perhaps linked to the ability to
execute a particular cell fate choice, is currently not known.
Here we used the mitochondrial activity as a surrogate for the
metabolic state of HSCs. Using in vivo multi-lineage blood
reconstitution assays, we show that long-term self-renewal
activity is restricted to phenotypic HSC subpopulations having
lower mitochondrial activity. By comparing mitochondrial
activity distributions of HSCs separated by their cell cycle phase,
we ﬁnd that during homeostasis as well as under acute stress,
quiescent and cycling HSCs have relatively similar mitochondrial
activity proﬁles. This shows that the distinct metabolic programs
of HSCs are rather indicative of fate choice (that is, self-renewal
versus commitment) and not per se a hallmark of the quiescent
(versus activated) state. Indeed, in vitro, in heterogeneous HSC
expansion cultures, divisional tracking experiments show that
actively self-renewing HSCs retain a low mitochondrial activity,
in marked contrast to differentiating cells that have activated
mitochondria. Finally, under differentiation culture conditions,
the chemical uncoupling of the electron transport chain forces
HSC to self-renew, a process that is accompanied by a reversible
decrease of mitochondrial mass by autophagy. Collectively, our
experiments reveal an intriguing relationship between HSC
metabolism and fate decision-making.
Results
HSCs show low mitochondrial activity and mass. To establish a
reliable marker for tracking the metabolic state of HSCs under-
going different fate choices, we ﬁrst employed ﬂow cytometry and
confocal microscopy to analyse the mitochondrial activity and
mass of phenotypically deﬁned HSC and MPP populations that
were isolated by the most commonly used combinations of
surface markers21,22 (Supplementary Fig. 1). We used
tetramethylrhodamine methyl ester (TMRM), a cell-permeable
dye that is readily sequestered by active mitochondria and reports
mitochondrial polarization that correlates with the level of
OXPHOS in a cell23,24. Each population displayed a distinct
level of TMRM intensity, giving a stepwise increase from the most
primitive to the most committed population as shown by ﬂow
cytometry (Supplementary Fig. 1a,b) and microscopy-based
read-outs (Supplementary Fig. 1c,d). The mitochondrial activity
was lowest in the LT-HSC population (Supplementary Fig. 1b),
which was suspected based on recent studies reporting a
preferential use of glycolysis in LT-HSCs7,11,25, and became
barely detectable by confocal microscopy (Supplementary
Fig. 1c,d).
We then asked whether HSCs and MPPs also show differences
in their mitochondrial mass. To this end, we employed an
R26-mito-EGFP mouse line26 ubiquitously expressing enhanced
green ﬂuorescent protein (EGFP) in the mitochondria of each
cell. An analysis of single cells isolated from these mice by
spinning disk microscopy revealed the lowest level of mito-
chondrial mass in the LT-HSC compartment (Supplementary
Fig. 1e,f). This is in accordance with previous work showing
that blocking HSC differentiation by TSC1-mediated mTOR
pathway inhibition is accompanied by a decrease in mito-
chondrial mass15. Additionally, FOXO3, a transcription factor
critical for the LT-HSC self-renewal27, promotes mitochondrial
mass reduction28. Thus, these results conﬁrm that under
homeostatic conditions, freshly isolated LT-HSCs are marked
by both low mitochondrial activity and mass.
Low mitochondrial activity marks LT-HSCs. Using in vivo
multi-lineage blood reconstitution assays, we next used
phenotypically deﬁned LKS (a population that contains all
multipotent stem and progenitor cells in the BM, thus also the
putative HSCs), ST- or LT-HSCs to test to which extent
mitochondrial activity levels could report stem cell function
(Fig. 1). First, we focused on LKS and utilized FACS to isolate two
cell fractions within the LKS compartment characterized by low
(LKS:TMRMlow) and high (LKS:TMRMhigh) TMRM intensity
levels. Then, we transplanted these two metabolically different cell
populations into lethally irradiated mice by using a double con-
genic allelic system (Fig. 1a). Long-term multi-lineage blood
reconstitution analysis showed that within the LKS population,
only cells with low TMRM intensity (that is, LKS:TMRMlow)
permitted long-term multi-lineage reconstitution (Fig. 1b,c).
Therefore, employing a metabolic read-out along with the
existing surface marker repertoire allows puriﬁcation of cells
with long-term reconstitution capacity from a poorly deﬁned
population (LKS) consisting mainly of MPPs.
Then, using the same sorting strategy on ST-HSCs, setting the
TMRM gates as shown in Supplementary Fig. 2, we compared the
ability of ST-HSC:TMRMlow and ST-HSC:TMRMhigh to
reconstitute the blood system (Fig. 1d,e). Strikingly, within the
ST-HSC population, the capacity to reconstitute the blood system
was almost exclusively restricted to the TMRMlow fraction
(Fig. 1e). Moreover, sorted LT-HSCs (Fig. 1d) could similarly
be separated into two functionally very distinct populations.
Only the population with low mitochondrial activity
(LT-HSC:TMRMlow, corresponding to B55% of the population)
was capable of long-term multi-lineage reconstitution, whereas
LT-HSC:TMRMhigh cells completely failed to do so (Fig. 1f).
Importantly, propidium iodide staining did not show any
measurable difference in viability between the four populations
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(Supplementary Fig. 3), and BM isolated based on differential
TMRM levels did not show signiﬁcant differences in engraftment
capability (Supplementary Fig. 4), ruling out that the lack of
engraftment was a result of differential cell death. Moreover, we
compared the homing capacity of transplanted cells and did not
ﬁnd any difference between HSCs isolated based on differential
mitochondrial activity levels (Supplementary Fig. 5).
Our in vivo data thus reveal a striking functional heterogeneity
in phenotypically deﬁned HSCs. The observation that LT-HSCs
with activated mitochondria (that is, LT-HSC:TMRMhigh) do not
show a signiﬁcant blood reconstitution suggests that these cells
may not be hierarchically related to ‘true’ LT-HSCs. They
may instead represent HSCs that give rise to long-term
lineage-restricted progenitor cells, as shown by in vivo single-
cell multi-lineage reconstitution assays performed on the
same immunophenotypes29. To test whether TMRMlow versus
TMRMhigh cells within the LT-HSC compartment contain
different levels of such lineage-biased progenitor cells, we used
CD41, a marker for megakaryocytes, to further separate the two
phenotypes. Previous studies have shown that CD41þ cells in
the HSC compartment have a strong myeloid bias30 and only
short- or intermediate-term repopulation activity29. In our hands,
LT-HSC:TMRMlow cells comprise B70% of cells that are
negative for CD41, in marked contrast to LT-HSC:TMRMhigh
cells, of which B50% are CD41 positive (Supplementary Fig. 6).
Therefore, the observed functional heterogeneity may at least be
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Figure 1 | Multi-lineage reconstitution capacity is restricted to the low mitochondrial activity cell fractions. (a) Competitive transplantation strategy
used to assess multi-lineage blood reconstitution levels from peripheral blood after 4, 8 and 16 weeks. (b,c) Within LKS, which contain all multipotent stem
and progenitor cells in the BM, long-term multi-lineage HSC function is restricted to TMRMlow cells (LKS:TMRMlow) (n¼8 for each condition; error bar:
s.e.m.; t-student, ***Po0.001). (d,e) In the phenotypically deﬁned ST-HSC compartment, stemness is restricted to TMRMlow cells (ST-HSC:TMRMlow)
(n¼9 for each condition; error bar: s.e.m.; t-student, **Po0.01). (d,f) In the phenotypically deﬁned LT-HSC compartment, stemness is restricted to
TMRMlow cells (LT-HSC:TMRMlow) (n¼ 9 for each condition; error bar: s.e.m.; t-student, ***Po0.001).
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partially explained by the presence of CD41þ megakaryocyte
progenitors that might have different mitochondrial activity levels
compared with functional LT-HSCs.
Low mitochondrial activity marks rare self-renewing HSCs.
After establishing low mitochondrial activity as a functional
discriminator of stemness, we tested whether this read-out
could be used to distinguish self-renewing from differentiating
HSCs in heterogeneous bulk cultures. To test whether
TMRM-based read-outs could be used to separate self-renewal
from differentiation divisions, 200 LT-HSCs from CD45.1 donor
mice were isolated based on surface marker expression and
expanded in vitro in serum-free medium containing a cocktail of
the self-renewing factors angiopoietin-like protein, insulin-like
growth factor binding protein 2, stem cell factor, ﬁbroblast
growth factor 1 and thrombopoietin31 (Supplementary Fig. 7).
After 5 days in culture, the cells were resorted by FACS based on
TMRMlow and TMRMhigh phenotypes, and transplanted into
lethally irradiated CD45.2 recipient mice (Supplementary Fig. 7a).
Of note, we found that the TMRM intensities of cultured cells are
substantially different from those of freshly isolated cells (Fig. 1b),
likely reﬂecting an inﬂuence of cell culture. Nonetheless,
consistent with our previous results using low TMRM
ﬂuorescence to directly isolate functional HSCs in vivo, a low
TMRM signal was also predictive of the long-term blood
reconstitution capacity of cultured HSCs (Supplementary
Fig. 7b). Analysis of peripheral blood chimerism 4 months after
grafting the cultured HSCs showed that TMRMlow cells induce
signiﬁcantly higher long-term multi-lineage blood reconstitution
levels compared with cells that had a high TMRM signal. This
suggested that self-renewing HSCs in culture can be detected
based on the same metabolic hallmark as freshly isolated HSCs
from the BM.
However, since it is known that a small fraction of cultured
HSCs can maintain their stem cell potential by remaining
quiescent even after prolonged time in culture (for example,
refs 32,33), the reconstitution from TMRMlow cells seen in
Supplementary Fig. 7 might have come from non-dividing HSCs.
To exclude this possibility and unequivocally identify self-
renewing cells in these bulk cultures, we created a cell-labelling
strategy that allowed us to track the precise number of divisions a
‘mother’ HSC had undergone in culture (Fig. 2a,b). Freshly
isolated LT-HSCs were uniformly labelled with carboxy-ﬂuor-
esceinsuccinimidyl ester (CFSE), a live cell-permeable dye that
allows cell division tracking34. With this tool, we FACS-sorted
cultured HSC daughter cells that underwent precisely one
division after 2 days and then further separated them into
TMRMlow and TMRMhigh subpopulations (Fig. 2b, lower panels).
Hundred cells of each population were transplanted into lethally
irradiated mice and long-term multi-lineage reconstitution was
analysed up to 16 weeks later. In line with our previous ﬁndings,
long-term multi-lineage reconstitution was once again restricted
to the TMRMlow subpopulation (Fig. 2c). Furthermore, secondary
transplantation showed long-term engraftment of the TMRMlow
fraction (Fig. 2d). These data establish low mitochondrial activity
as a read-out for self-renewal divisions of HSCs in vitro.
Moreover, our experiments reveal that low mitochondrial
activity is a hallmark not only of quiescent LT-HSC in vivo, as
could be hypothesized based on their metabolic state of
preferentially undergoing anaerobic glycolysis9,10, but also of
cycling stem cells that have undergone a self-renewing cell
division in vitro. Notably, a cell cycle phase analysis of HSCs
in vivo showed that quiescent and cycling LT-HSCs have similar
levels of mitochondrial activity, both under homeostatic
conditions (Fig. 3a,b) and when stimulated by interferon-alpha
(IFN-a) to exit dormancy35 (Fig. 3c,d) and maintaining stem cell
potential (Supplementary Fig. 8). In the latter experiments,
analysis of mitochondrial activity combined with cell cycle phase
analysis was performed by MitoTracker Deep Red staining that
persists in the cells after ﬁxation10,36 and gave consistent read-
outs on the metabolic proﬁles of the different haematopoietic
compartments (Supplementary Fig. 9).
HSC fate speciﬁcation by electron transport chain uncoupling.
With a read-out identiﬁed to discriminate HSC self-renewal from
differentiation, we then tested whether HSC fate could be
manipulated by modulation of mitochondrial activity in vitro
(Fig. 4). Speciﬁcally, we chose culture conditions that would
rapidly push HSCs to differentiate into highly proliferative MPPs
and asked whether blocking the establishment of a mitochondrial
membrane potential would result in the maintenance of stemness
(Fig. 4a). For that purpose, we used carbonyl cyanide-p-
triﬂuoromethoxyphenylhydrazone (FCCP), which permeabilizes
the inner mitochondrial membrane and disrupts its potential
(Supplementary Fig. 10), to uncouple electron transport from
ATP generation.
Long-term blood reconstitution assays show that LT-HSC:
TMRMlow cultured for 5 days under differentiation-inducing
conditions (SCF, Flt3, IL-3 and IL-6) and in the presence of FCCP
exhibited substantially higher levels of long-term multi-lineage
blood reconstitution in lethally irradiated recipient mice,
compared with cells cultured in the absence of FCCP (Fig. 4b).
By labelling HSCs with CFSE and tracking their divisional
history, we could rule out that this effect was due to an induction
of quiescence upon FCCP administration, since all cells in culture
had divided multiple times (Supplementary Fig. 11). Therefore,
by disrupting the inner mitochondrial membrane potential, HSCs
that would normally rapidly differentiate can be converted to a
state of self-renewing division. These data demonstrate that HSC
self-renewal divisions can be executed independently of the
establishment of a mitochondrial potential. Interestingly, rapidly
dividing, self-renewing embryonic stem cells have mitochondria
with a low mitochondrial membrane potential indicative of
OXPHOS-independent metabolism37. Furthermore, during
reprogramming of ﬁbroblasts to the induced pluripotent stem
cell state, a metabolic switch from OXPHOS to glycolysis is
required24. Of note, LT-HSC:TMRMhigh treated with FCCP failed
to revert to functional stem cells (Supplementary Fig. 12),
enforcing the hypothesis that LT-HSC:TMRMhigh cells may be
composed of more committed haematopoietic cells. Indeed,
LT-HSC:TMRMlow are exclusively composed by CD48 cells,
while the TMRMhigh fraction contains both CD48 and
CD48þ cells (Supplementary Fig. 13), as well as CD41þ cells
(Supplementary Fig. 6).
Chemical uncoupling increases autophagy in HSCs. FCCP is
known to promote mitophagy38 and, in turn, autophagy has been
demonstrated to be critical for LT-HSC self-renewal27,28,39.
Accordingly, the inhibition of autophagy gives rise to an increase
in the mitochondrial mass in LT-HSCs through an accumulation of
mitochondria damaged by ROS20. Therefore, we postulated that the
observed metabolic speciﬁcation of HSC fate (Fig. 4b) could occur
through a reversible decrease of mitochondrial mass via autophagy.
To test this, we used spinning disk confocal imaging at single cell
level to analyse whether the treatment of HSCs with FCCP under
differentiation-inducing conditions is accompanied by a decrease of
mitochondrial mass (TOMM20) and/or elevation of autophagy
(LC3B) (Fig. 4c). The rate of autophagosomal turnover was assessed
by blocking their lysosomal degradation by Pepstatin A for 4 h prior
to ﬁxation. This analysis showed that chemical uncoupling by
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Figure 2 | A low mitochondrial activity marks self-renewing HSCs. (a) Experimental paradigm to assess mitochondrial activity as a discriminator of
self-renewing from differentiating LT-HSCs in culture. Freshly isolated LT-HSCs were labelled with CFSE. At the end of the culture, cells that divided one
time were further sorted into TMRMlow and TMRMhigh phenotypes and transplanted into lethally irradiated recipient mice together with helper cells. Blood
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transplanted into lethally irradiated recipients. (c) The TMRMlow fraction of the ﬁrst generation of daughter cells (that is, dividing one time) exhibited
strikingly higher long-term multi-lineage blood reconstitution efﬁciency compared with TMRMhigh cells, providing evidence for self-renewing versus
differentiating HSC divisions in culture (n¼ 10 for each condition). Assessment of blood chimerism is shown for total blood (top panel) as well as the
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NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13125 ARTICLE
NATURE COMMUNICATIONS | 7:13125 | DOI: 10.1038/ncomms13125 |www.nature.com/naturecommunications 5
FCCP drastically decreased the mitochondrial area as measured by
TOMM20 in LT-HSC (Fig. 4d). This phenomenon is reversed in
the presence of protease inhibitor Pepstatin A, which causes the
accumulation of autophagosomes before mitochondrial autophagy
can occur. Thus, while autophagosomal area as measured by LC3B
immunoﬂuorescence seems similar in FCCP-treated versus control
HSCs (Fig. 4e), further treatment with protease inhibitor Pepstatin
A shows a drastic increase in LC3B autophagosome accumulation
in FCCP-treated cells, but not in control cells. This effect is
especially clear, when the autophagosomal area is normalized to the
mitochondrial area. The ratio between the autophagosomal and
mitochondrial area is higher in FCCP-treated cells compared to
control cells, and this effect is further emphasized by the inhibition
of lysosomal degradation of the autophagosomes by Pepstatin A
(Fig. 4f). Taken together, these results point to the reduction in
mitochondrial mass in LT-HSCs upon FCCP treatment as a result
of both increased autophagosome formation and accelerated
lysosomal processing of the autophagosomes. Consistently, gene
expression analysis revealed an increase in expression levels of the
E3 ubiquitin ligase PARKIN (encoded by PARK2), involved
in the ubiquitination of depolarized mitochondria40, and of the
autophagic receptor Sqstm141 (Fig. 4g). Therefore, the chemical
uncoupling of the electron transport chain increases the level of
autophagy in LT-HSCs, and the mitochondria serve as a primary
target for the removal by autophagosomes.
Discussion
Collectively, our data show that in HSCs, mitochondrial metabolism
and function are intricately linked. Speciﬁcally, we demonstrate that
the distinct metabolic program of HSCs is more than an adaptation
to a speciﬁc microenvironment in the BM niche9,10, but seems
sufﬁcient to drive the decision of stem cells to undergo self-renewal
or commitment. It should be noted, however, that the
mitochondrial activity is a transient cell state that may strongly
depend on endogenous conditions such as the microenvironment.
Cells may not be readily interconvertible between high and low
mitochondrial activity levels (Supplementary Fig. 12).
Using a gene-knockout approach, previous work has shown
that loss of function of PTPMT1 phosphatase within the inner
mitochondrial membrane is sufﬁcient to block differentiation
and promote self-renewal in vivo, apparently through the
accumulation of phosphatidylinositol phosphate substrates that
enhance endogenous UCP2 activity and lower mitochondrial
aerobic metabolism11. However, loss of PTPMT1 failed to drive
preferential HSC self-renewing divisions in vitro, presumably
because of the oxidative stress imposed by classic culture
conditions. Loss of PTPMT1 is also an irreversible treatment
that results in the inability of stem cells to differentiate in vivo,
causing abnormal expansion of the HSC compartment and
ultimately a failure of haematopoiesis. Here we show that
chemical uncoupling of the electron transport chain is sufﬁcient
to reversibly metabolically modulate HSCs via induction of
autophagy, maintaining their capacity for proper differentiation
and functional blood reconstitution.
We think that our approach could be useful to expand HSCs
for clinical applications. Moreover, the availability of a functional
marker for HSC self-renewal in the form of low mitochondrial
potential as measured by TMRM, extensively validated here for
both in vitro and in vivo applications, should facilitate investiga-
tions of molecular mechanisms of HSC fate decision-making.
Methods
Mice. C57Bl/6J and C57Bl/6J Ly5.1 were purchased from Charles River
Laboratories International and maintained at the Center for Studying Living
System (CAV) at EPFL in micro-isolator cages. Mice were provided continuously
with sterile food, water and bedding. All in vivo procedures were carried out in
accordance with the Swiss law and EPFL policies.
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cytometry analysis shows overlapping MitoTracker proﬁles of quiescent and cycling HSCs in IFN-a condition. Similarly, the proportion of MitoTrackerlow and
MitoTrackerhigh cells in quiescent and cycling HSCs remains comparable (MitoTrackerlow: P¼0.32, MitoTrackerhigh: P¼0.54; n¼ 3; error bar: s.e.m.,
t-student), suggesting that mitochondrial activity is independent of HSC cell cycle state even under acute stress conditions.
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Antibodies. The following antibodies were used: rat mAbs against 1/200 cKit
(2B8) (Biolegend Cat. no. 105814), 1/100 Sca1 (D7) (Biolegend Cat. no. 108112),
1/100 CD150 (TC-15-12F12.2), 1/25 CD34 (RAM34), 1/100 CD48 (HM48-1)
(Biolegend Cat. no. 103418), 1/200 CD45.2 (104) (Biolegend Cat. no. 109820),
1/200 CD45.1 (A20) (Biolegend Cat. no. 110706), 1/1,000 Gr1 (RB6-8C5)
(Biolegend Cat. no. 108412), 1/750 F4/80 (BM8), 1/500 CD19 (6D5) (Biolegend
Cat. no. 115507), 1/200 CD3 (17A2) (Biolegend Cat. no. 100206), 1/500
CD16/CD32 (2.4G2) (BD Cat. no. 553141). The antibodies were purchased from
Biolegend, eBiosciences and BD (Becton, Dickinson and Company). A mixture of
biotinylated mAbs against CD3, CD11b, CD45R/B220, Ly-6G, Ly-6C and TER-119
was used as lineage cocktail (BD).
Flow cytometry and ﬂuorescence activated cell sorting. Flow cytometry ana-
lysis of haematopoietic stem and progenitor cells was performed on freshly isolated
BM. BM was extracted from crushed femora and tibia. Cell suspensions were
ﬁltered through a 70 mm cell strainer and erythroid cells were eliminated by
incubation with red blood cells lysis buffer (eBioscences). Lineage-positive cells
were removed with a magnetic lineage depletion kit (Miltenyi Biotech). Cell
suspensions were stained with a panel of speciﬁc antibodies for stem and
progenitor cells and analysed or FACS-sorted on a BD LSRII and BD FACS Aria II,
respectively.
Analysis of mitochondrial activity. Freshly isolated BM cells were incubated at
37 C for 1 h with 200 nM TMRM (Invitrogen) and then stained with speciﬁc
antibodies for the different haematopoietic stem/progenitor cell compartments.
Labelled cells were FACS-sorted or analysed by ﬂow cytometry. For confocal
imaging, LT-HSC, ST-HSC, MPPs and committed progenitors were sorted and
placed on adherent poly-L-lysine (PLL)-coated glass slides for 6 h. 20 nM TMRM
was then added in the media and live cell images were acquired on a Leica SP5
confocal microscope. For MitoTracker Deep Red (Invitrogen) staining, cells were
incubated at 200 nM for 1 h at 37 C.
Cell cycle staining. Sorted HSCs were ﬁxed and permeabilized using
Cytoﬁx/Cytoperm plus kit (BD), according to the manufacturer’s instruction. Fixed
cells were then stained overnight with FITC Ki67 (BD) at 4 C, and 10min by
Hoechst 33342 (Invitrogen).
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Figure 4 | Modulation of mitochondrial metabolism alters HSC fate through autophagy. (a) LT-HSC:TMRMlow (LKS CD150þ CD34 TMRMlow)
cultured for 5 days under differentiation conditions in the presence or absence of FCCP were transplanted in lethally irradiated recipient mice together with
2*106 helper cells. (b) Cells cultured in the presence of FCCP show high levels of multi-lineage reconstitution, in contrast to controls lacking FCCP that
result in rapid differentiation (error bar: s.e.m.; t-student, **Po0.01 and *Po0.05). (c) Mitochondrial mass (TOMM20, cyan) and autophagosomes (LC3B,
red) in different haematopoietic stem/progenitor cell populations. Images represent maximum intensity projections of the corresponding Z-stacks
(0.28mm step) Scale bar: 5 mm. (d–f) Quantiﬁcation of the mito-EGFP (d), LC3B (e) and mito-EGFP/LC3B ratio intensity-thresholded areas (f). (g) Gene
expression analysis on key autophagosomal and mitophagic genes was performed on LT-HSCs treated over 5 days with FCCP (error bar: s.e.m.; t-student,
***Po0.001, **Po0.01 and *Po0.05).
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CFSE staining. Freshly sorted LT-HSCs were incubated for 20min at 37 C with
1:400 CFSE stock solution (Cayman chemicals; CFSE cell division assay kit). The
cells were pelleted and resuspended in 1ml of Stemline II (Sigma) containing 10%
FBS for 20min at 37 C. Afterwards, the cells were washed twice with 1ml of
Stemline II (Sigma) and put in culture.
HSC culture. HSCs were cultured under ‘expansion’ conditions in U-bottom
96-well plates for 5 days. Cultures were maintained in Stemline II (Sigma)
supplemented with 10mgml 1 Heparin (Sigma), 100 ngml 1 SCF (R&D
Systems), 2 ngml 1 Flt3 ligand (R&D), 20 ngml 1 TPO (R&D Systems),
10 ngml 1 FGF-1 (Invitrogen), 500 ngml 1 IGFBP2 (R&D Systems) and
100 ngml 1 AngL-3 (R&D Systems)31. At the end of the culture period, cells were
stained with TMRM and analysed or sorted by ﬂow cytometry. To induce
differentiation, HSCs were cultured in a basal medium (Stemline II containing
100 ngml 1 SCF and 2 ngml 1 Flt3 ligand) supplemented with 20 ngml 1 IL-3
(R&D Systems) and 100 ngml 1 IL-6 (R&D Systems). For some experiments,
5 mM carbonyl cyanide 4-(triﬂuoromethoxy)phenylhydrazone (FCCP) (Sigma) was
added at the medium. FCCP stock solution was prepared by dissolving the powder
in ethanol at 10mM concentration.
Transplantations. C57Bl/6 Ly5.2 female mice (8–12-weeks-old) were lethally
irradiated on an X-ray irradiator at 850 rads in two split doses of 425 rads
separated by 3–5 h and transplanted with donor cells derived from C57Bl/6 Ly5.1
mice and competitor cells derived from F1 C57Bl/6 Ly5.1/5.2 mice. For LKS
transplants, 1,000 LKS (TMRMlow or TMRMhigh) donor cells were transplanted
together with 250 103 total BM competitor cells in recipient mice. For LKS
CD150þCD34 (‘LT-HSC’) and LKS CD150þ CD34þ (‘ST-HSC’) transplants,
80 LT-HSC (TMRMlow or TMRMhigh) or 80 ST-HSC (TMRMlow or TMRMhigh)
were transplanted together with 250 103 total BM competitor cells in recipient
mice. Peripheral blood was collected at 4, 8 and 16 weeks to determine the
the percentage of chimerism. For transplantation of in vitro-cultured LT-HSCs, the
progeny of 200 LT-HSCs cultured for 5 days were FACS-sorted based on their
TMRM signal (TMRMlow or TMRMhigh) and transplanted together with 2 106
helper cells. Helper cells were derived from BM of C57Bl/6 Ly5.1/5.2 mice that
were depleted for Sca1 and CD150 positive cells (Miltenyi Biotech). Peripheral
blood was collected at 4, 8 and 16 weeks to determine the percentage of chimerism.
For the CFSE-TMRM transplants, LT-HSCs were sorted and stained for CFSE. At
the end of a 2-day culture period, cell progeny having undergone one division were
stained with TMRM and resorted based on TMRMlow and TMRMhigh signals. Each
recipient mouse was injected with 100 cells of either population together with
2 106 helper cells. Peripheral blood was collected at 4, 8 and 16 weeks to
determine the percentage of chimerism.
For transplants of cultured HSC exposed to the uncoupler FCCP, 100
LT-HSC:TMRMlow cells were cultured for 5 days under differentiation-inducing
conditions in the presence or absence of 5 mM FCCP. FCCP was replenished every
24 h. Cell progeny were transplanted in lethally irradiated recipient mice together
with 2 106 helper cells. Peripheral blood was collected at 4, 8, 12 and 16 weeks to
determine the level of chimerism.
For secondary BM transplantation, secondary C57Bl/6 Ly5.2 recipient mice
were lethally irradiated as described above and transplanted with 3 million BM cells
from the primary recipients. Peripheral blood was collected at 4, 8 and 16 weeks to
determine the level of chimerism.
HSC homing. C57Bl/6 Ly5.2 mice were lethally irradiated on an X-ray irradiator at
850 rads in two split doses of 425 rads separated by 3–5 h and transplanted with
donor cells derived from C57Bl/6 Ly5.1/5.2. Four thousand LT-HSC (TMRMlow or
TMRMhigh) were transplanted in recipient mice. BM was collected after 16 h to
determine the percentage of homed donor-derived cells42.
Analysis of mitochondrial mass and autophagy level. For the live cell
mitochondrial mass measurements, freshly isolated BM cells from R26-Mito-EGFP
mice were stained with speciﬁc antibodies for the different haematopoietic
stem/progenitor cell compartments. Labelled cells were FACS-sorted and live cells
analysed by spinning disk confocal microscopy on a Visitron CSU W1 microscope.
Mitochondrial mass was quantiﬁed as the intensity-thresholded area of mito-EGFP
signal. For the autophagy-level study, freshly isolated BM cells were stained
with speciﬁc antibodies for the different haematopoietic stem/progenitor cell
compartments. LT-HSC:TMRMlow cells were FACS-sorted, separated in halves and
cultured in differentiation-inducing medium, deﬁned as basal medium (Stemline II
containing 100 ngml l SCF and 2 ngml 1 Flt3 ligand) supplemented with
20 ngml 1 IL-3 (R&D Systems) and 100 ngml 1 IL-6 (R&D Systems). Cells were
cultured for 5 days either with addition of 5 mM FCCP or an equivalent amount of
vehicle (EtOH). On the last day of culture, each population was separated in halves
and further cultured for 4 h in the following conditions: FCCP-treated cells were
either cultured with 5 mM FCCP and 1 mM Pepstatin A or with 5 mM FCCP and an
equivalent amount of vehicle (DMSO), while the control vehicle-treated cells were
either with vehicle (EtOH) and 1 mM Pepstatin A or with vehicle alone
(EtOHþDMSO). After 4 h, the cells were ﬁxed with 4% formaldehyde for 5min at
room temperature, permeabilized with MeOH for 5min, washed with PBS pH 7.4
and blocked for 1 h with 2% goat serum in PBS pH 7.4 with slight agitation. The
cells were incubated for an additional 2 h with the rabbit anti-LC3B (Abcam,
ab51520) and mouse anti-TOMM20 (Abcam ab56783) primary antibodies with
slight agitation, washed three times with PBS pH 7.4, incubated with goat
anti-mouse Alexa488 and goat anti-rabbit Alexa647 secondary antibodies with
slight agitation for 1 h and washed three times with PBS pH 7.4. Stained cells
were imaged by spinning disk confocal microscopy on a Visitron CSU W1
microscope. Mitochondrial and autophagosomal mass were quantiﬁed as the
intensity-thresholded area of TOMM20 and LC3B signal, respectively.
In vivo activation of HSC. HSC were activated to exit dormancy by IFN-a
treatment following published protocols35. Brieﬂy, subcutaneous injections in
C57Bl/6J mice were carried out with 10,000U of IFN-a (R&D systems) 48 and 24 h
prior to BM extraction. Control mice were injected with an equivalent volume of
the vehicle (PBSþ 0.1% BSA).
QPCR analysis. LT-HSCs were lysed after 5 days culture in lysis buffer from ZR
RNA MicroPrep (Zymo Research) and RNA extraction was performed accordingly
to the manufacturer’s instruction. RNA was eluted and resuspended in 6 ml of
H2O. Four microlitres of RNA was retro-transcribed to cDNA with Vilo SScript
system (Invitrogen). Subsequently cDNA was diluted ﬁve times in water. For
QPCR 1.5 ml of cDNA, 5 ml of Power Syber Green mastermix (Applied Biosystem)
and 200 nM of primers were added to a ﬁnal volume of 10 ml for each reaction. The
reactions were performed on 7900HT system (Applied Biosystem). Primer
sequences (50-30) are the following: LC3-F GTCACCCAGGCGAGTTACC; LC3-R
TTACAGCGGTCGGCGAAG; Sqstm1-F GCTGAAGGAAGCTGCCCTAT;
Sqstm1-R TTGGTCTGTAGGAGCCTGGT; Park2-F CCGAATCACCTGACGGT
TCA; Park2-R TCTGGCTGCTTCTGAATCCC; Arbp-F AGATTCGGGATATGC
TGTTGG; Arbp-R AAAGCCTGGAAGAAGGAGGTC.
Statistics. Data were statistically analysed by Student’s t-test, one-way ANOVA
followed by Bonferroni’s multiple comparison test and Mann–Whitney test.
Data availability. The authors declare that all relevant data are contained within
the article and Supplementary ﬁles, or are available from the authors on request.
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